Jubilant Organosys has entered a Memorandum of Understanding (MoU) in Washington, DC with the University of Alabama at Birmingham (UAB), and Southern Research Institute for a joint venture (JV). The JV will focus on leveraging their collective innovation and enabling technologies in the areas of oncology, metabolic disease and infectious diseases.
The details can be read here.
No comments:
Post a Comment